Current Trends for Regulatory Requirements of Elemental Impurity in Drug Substance for Regulatory Market

Journal Title: Der Pharma Chemica - Year 2023, Vol 16, Issue 1

Abstract

The presence of elemental impurities in drug substances has gained increasing attention in the pharmaceutical industry due to their potential impact on product safety and efficacy. Regulatory agencies worldwide have established guidelines and requirements to ensure the control and mitigation of elemental impurities in drug substances and products. This review article provides a comprehensive analysis of the regulatory landscape surrounding elemental impurity control, focusing on both drug substances and the broader pharmaceutical market.

Authors and Affiliations

Chetna Malwal1*, Rashid Azeez1 and Vinod Bairagi

Keywords

Related Articles

Density, Ultrasonic Velocity, Viscosity and their Excess Parameters of Some Binary Liquid Mixtures of Cumene with Aromatic Hydrocarbons at 298.15 K

Density (ρ), viscosity (η) and sound velocity (u) of binary mixtures of ethyl benzene, toluene, mesitylene with cumene have been measured over the entire range of composition at temperature 298.15 K. From the experimenta...

Fabrication and Characterization of Cefixime Containing Micro Emulsion for Parenteral Drug Delivery System

The development of an injectable or parenteral micro emulsion formulation of the antibiotic cefixime was the aim of this investigation. We identified cefixime, which is easily soluble in methanol and propylene glycol and...

To Evaluate the Interaction of Zandopa® Powder and Parkitidin Tablet in HaloperidolInduced Catalepsy Model in Rats

Herb Drug Interaction (HDIs) is defined as an interaction between herbal medicinal products and allopathic drugs when administered concomitantly. HDIs alter the body’s function pharmacodynamically and pharmacokinetically...

Development and Validation of Simplified RP-HPLC Method for Quantification of Candesartan Cilexetil in Commercial Formulations

In order to produce antihypertensive effects, Candesartan Cilexetil (CC), a candesartan inactive prodrug, was quickly converted into active candesartan after absorption in the Gastrointestinal (GI) tract. This research s...

Green Synthesis and Evaluation of Pharmaceutical Properties of Euphorbia umbellata (Pax) Bruyns Latex

Present work explores the synthesis and application of Silver Nanoparticles (AgNPs) using latex from Euphorbia umbellata. The study characterizes the synthesized AgNPs and evaluates their antibacterial, antifungal and la...

Download PDF file
  • EP ID EP742478
  • DOI 10.4172/0975-413X.16.1.192-196
  • Views 17
  • Downloads 0

How To Cite

Chetna Malwal1*, Rashid Azeez1 and Vinod Bairagi (2023). Current Trends for Regulatory Requirements of Elemental Impurity in Drug Substance for Regulatory Market. Der Pharma Chemica, 16(1), -. https://europub.co.uk/articles/-A-742478